Relationship among drug delivery behavior, degradation behavior and morphology of copolylactones derived from glycolide, L-lactide and ε-caprolactone

被引:24
作者
Cai, Q [1 ]
Bei, JZ [1 ]
Wang, SG [1 ]
机构
[1] Chinese Acad Sci, Inst Chem, Ctr Mol Sci, Beijing 100080, Peoples R China
关键词
poly(lactide-co-glycolide-co-caprolactone); (r-PGLC); poly(lactide-co-glycolide) (PLGA); drug release behavior; degradation; morphology;
D O I
10.1002/pat.161
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
A series of copolylactones was synthesized by ring-opening copolymerization of glycolide, L-lactide and epsilon-caprolactone, using stannous octoate as catalyst. The in vitro degradation behaviors of them were studied and data demonstrated different degradation rates which mainly depended on the compositions. Investigation of the 5-fluorouracil (5-Fu) release from these copolylactones revealed that the composition, degradation rate and the morphology of the polymeric matrix played an important role on the drug release kinetics. A sustained 5-Fu release without initial time lag was obtained from random poly(lactide-co-glycolide-co-caprolactone) (r-PGLC) drug carrier, and it differed from the cases of polylactide (PLA) or random poly(lactide-co-glycolide) (PLGA), which usually showed an initial time lag or biphasic drug release behavior. It was due to the low, glass transition temperature (T-g) of the r-PGLC and the drug would diffuse faster in rubbery state under the experimental temperature. Furthermore, a significant change in the drug release behavior of r-PGLC was observed when the temperatures were changed around the T-g of the drug carrier, which implied that the drug release behavior could be regulated by adjusting the morphology of the drug carrier. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:105 / 111
页数:7
相关论文
共 17 条
[1]   Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid polyglycolic acid copolymers [J].
Athanasiou, KA ;
Niederauer, GG ;
Agrawal, CM .
BIOMATERIALS, 1996, 17 (02) :93-102
[2]   FLUOROURACIL, DOXORUBICIN, CISPLATIN AND ALTRETAMINE IN THE TREATMENT OF METASTATIC CARCINOMA OF UNKNOWN PRIMARY [J].
BECOUARN, Y ;
BRUNET, R ;
BARBEGASTON, C .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (05) :861-865
[3]   PREPARATION AND CHARACTERIZATION OF 5-FLUOROURACIL-LOADED MICROPARTICLES AS BIODEGRADABLE ANTICANCER DRUG CARRIERS [J].
BOISDRONCELLE, M ;
MENEI, P ;
BENOIT, JP .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (02) :108-114
[4]   Synthesis and degradation of a tri-component copolymer derived from glycolide, L-lactide, and ε-caprolactone [J].
Cai, Q ;
Bei, JZ ;
Wang, SG .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2000, 11 (03) :273-288
[5]  
Cai Q, 1999, ACTA POLYM SIN, P761
[6]   THE PREPARATION AND CHARACTERIZATION OF POLY(LACTIDE-CO-GLYCOLIDE) MICROPARTICLES .2. THE ENTRAPMENT OF A MODEL PROTEIN USING A (WATER-IN-OIL)-IN-WATER EMULSION SOLVENT EVAPORATION TECHNIQUE [J].
JEFFERY, H ;
DAVIS, SS ;
OHAGAN, DT .
PHARMACEUTICAL RESEARCH, 1993, 10 (03) :362-368
[7]   NEW METHODS OF DRUG DELIVERY [J].
LANGER, R .
SCIENCE, 1990, 249 (4976) :1527-1533
[8]  
Lewis D.H., 1990, Biodegradable polymers as drug delivery systems, P1
[9]   STRUCTURE PROPERTY RELATIONSHIPS IN THE CASE OF THE DEGRADATION OF MASSIVE POLY(ALPHA-HYDROXY ACIDS) IN AQUEOUS-MEDIA .2. DEGRADATION OF LACTIDE-GLYCOLIDE COPOLYMERS - PLA37.5GA25 AND PLA75GA25 [J].
LI, SM ;
GARREAU, H ;
VERT, M .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 1990, 1 (03) :131-139
[10]   BIODEGRADATION AND BRAIN-TISSUE REACTION TO POLY(D,L-LACTIDE-CO-GLYCOLIDE) MICROSPHERES [J].
MENEI, P ;
DANIEL, V ;
MONTEROMENEI, C ;
BROUILLARD, M ;
POUPLARDBARTHELAIX, A ;
BENOIT, JP .
BIOMATERIALS, 1993, 14 (06) :470-478